Tempus ECG-MR

Items

1. Sep 28

   FDA clears Tempus ECG-MR

   The FDA granted 510(k) clearance to an AI product that analyzes standard 12-lead ECGs to flag signs of undiagnosed moderate or severe mitral regurgitation in at-risk patients 65 and older, as an early-detection referral tool.